Showing: 1-20 of 1

Antipsychotic Drug

Ark. judge affirms $181 million in legal fees

LITTLE ROCK, Ark. | An Arkansas judge says Johnson & Johnson must pay $181 million in fees to attorneys who successfully argued the pharmaceutical company committed Medicaid fraud in the marketing of its antipsychotic drug Risperdal.

February 01, 2013 4:44 pm
Follow The Times

Featured Businesses



Do you agree with The Times Editorial Board's endorsements in statewide races?

View Results